1999
DOI: 10.1016/s0960-894x(99)00537-5
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: A new class of anti-HIV agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
28
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 45 publications
(29 citation statements)
references
References 14 publications
1
28
0
Order By: Relevance
“…However, we failed to reproduce their results in our assay system [19]. Through the screening of our chemical library and a derivatization study, we found some arylpiperazinyl fluoroquinolones that inhibit HIV-1 replication both in acutely and in chronically HIV-1-infected cells [12,19,20]. These results were confirmed by another group [3].…”
mentioning
confidence: 70%
“…However, we failed to reproduce their results in our assay system [19]. Through the screening of our chemical library and a derivatization study, we found some arylpiperazinyl fluoroquinolones that inhibit HIV-1 replication both in acutely and in chronically HIV-1-infected cells [12,19,20]. These results were confirmed by another group [3].…”
mentioning
confidence: 70%
“…Our results therefore suggest that WM5 may effectively sequester TAR RNA affecting HIV-1 transcription. Fluoroquinolone derivatives have recently been shown to be potent and selective inhibitors of HIV-1 replication (5,22,29,36,55). A representative compound of the series, K12, has been reported to inhibit HIV-1 transcription, reducing the synthesis of HIV-1 mRNA in chronically infected cells without significantly affecting Tat activity (5).…”
Section: Discussionmentioning
confidence: 99%
“…Quinolone derivatives have been shown to inhibit HIV-1 replication in de novo-and chronically infected cells (4,5,22,29,(35)(36)(37)55). A new fluoroquinolone, K12, bearing an omethoxyphenyl-piperazinyl group and a difluoromethoxyl group at positions 7 and 8, respectively, was reported to have strong and selective anti-HIV-1 activity (4).…”
mentioning
confidence: 99%
“…Several new derivatives have been synthesized and evaluated for antibacterial activity against many bacterial strains such as P. aeruginosa, K. pneumoniae, S. pneumoniae, S. aureus, S. epidermis etc. [9][10][11][12] Fluoroquinolones analogs with antitubercular [13][14] , anti-fungal 15 , anti-viral 16 activities are well known. Many research endeavours are being undertaken to elaborate the possible role of fluoroquinolones in carcinogenesis and mutagenesis [17][18] .…”
Section: Introductionmentioning
confidence: 99%